NIH grants plummeted $2.3 billion in Trump’s first months, as federal-academia partnership crumbles

Taking stock of the drug industry, from the lab to the medicine chest

April 24, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

National Institutes of Health STAT+ | NIH grants plummeted $2.3 billion in Trump's first months, as federal-academia partnership crumbles As Trump administration nears its 100th day, the partnership that has been propelling American biomedical innovation is imperiled By Megan Molteni, J. Emory Parker, and Jonathan Wosen Public health leaders, distrustful of RFK Jr., stand up project to defend vaccines  The "Vaccine Integrity Project" will be aimed at assessing the best ways for vaccine proponents to safeguard vaccination policy and information. By Helen Branswell Pharma tariffs, and a 'sunshine day' for biotech stocks STAT reporters chat about pharma tariffs, the latest recovery in biotech stocks, and disappointing data from a Bristol Myers Squibb drug. By Elaine Chen, Adam Feuerstein, and Allison DeAngelis Adobe STAT+ | Prestigious journal gets U.S. attorney letter, Trump's HIV cuts slammed This week in health care politics and policy: A Medicaid work requirements lesson, Trump criticized on HIV cuts, and NEJM gets an inquiry from a top U.S. attorney. By John Wilkerson

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser